SCHEMBL6926244

SCHEMBL6926244

c1ccc(Cn2c3ccccc3c3c(OCCNC4CCC4)cccc32)cc1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.47
ALDH1A1 P00352 3/20 0.47
CYP19A1 P11511 1/20 0.43
HTR6 P50406 2/20 0.42
HTR1A P08908 2/20 0.42
UTS2R Q9UKP6 1/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
FOXM1 Q08050 1/20 0.40
MCL1 Q07820 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
P2RX4 Q99571 1/20 0.39
PLA2G2A P14555 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6927422 0.96 CYP19A1 (0.44) KDM4EALDH1A1CYP19A1HTR6HTR1A
SCHEMBL6924154 0.91 SLC6A2 (0.52) KMT2AMEN1SLC6A2SLC6A4SLC6A3
SCHEMBL6921596 0.85 HTR1A (0.43) KDM4EALDH1A1CYP19A1HTR6HTR1A
SCHEMBL6927871 0.82 HTR6 (0.54) CYP19A1HTR6UTS2RMCL1PLA2G2A
SCHEMBL6924418 0.82 HTR1B (0.51) CYP19A1HTR6UTS2RMCL1SLC6A4
SCHEMBL7505923 0.81 ACHE (0.51) HTR1AKMT2AMEN1
SCHEMBL6921216 0.80 HTR1B (0.53) CYP19A1HTR6HTR1AUTS2RKMT2A
SCHEMBL6924383 0.79 ADRB2 (0.50) KDM4ECYP19A1HTR6HTR1AUTS2R
SCHEMBL6925119 0.79 HTR1B (0.54) CYP19A1HTR6HTR1AUTS2RKMT2A
SCHEMBL6921654 0.79 HTR6 (0.49) KDM4ECYP19A1HTR6HTR1AUTS2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6514968-B1 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising PHARMACIA & UPJOHN COMPANY 2003-02-04 US claimed
EP-1210329-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-06-05 EP claimed
WO-2001017963-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2001-03-15 WO claimed
US-6514968-B1 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising PHARMACIA & UPJOHN COMPANY 2003-02-04 US disclosed
EP-1210329-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-06-05 EP disclosed
WO-2001017963-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2001-03-15 WO disclosed